Journal article

Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome

SEM Stephenson, G Costain, LER Blok, MA Silk, TB Nguyen, X Dong, DE Alhuzaimi, JJ Dowling, S Walker, K Amburgey, RZ Hayeems, LH Rodan, MA Schwartz, J Picker, SA Lynch, A Gupta, KJ Rasmussen, LA Schimmenti, EW Klee, Z Niu Show all

American Journal of Human Genetics | Published : 2022

Abstract

Neurodevelopmental disorders are highly heterogenous conditions resulting from abnormalities of brain architecture and/or function. FBXW7 (F-box and WD-repeat-domain-containing 7), a recognized developmental regulator and tumor suppressor, has been shown to regulate cell-cycle progression and cell growth and survival by targeting substrates including CYCLIN E1/2 and NOTCH for degradation via the ubiquitin proteasome system. We used a genotype-first approach and global data-sharing platforms to identify 35 individuals harboring de novo and inherited FBXW7 germline monoallelic chromosomal deletions and nonsense, frameshift, splice-site, and missense variants associated with a neurodevelopmenta..

View full abstract